Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Cubic Digital Technology
300344
Ningbo Shuanglin Auto Parts
300100
CN Stock MarketDetailed Quotes
002004 Huapont Life Sciences
- 4.25
- -0.06-1.39%
Market Closed Jan 10 15:00 CST
8.41BMarket Cap33.73P/E (TTM)
4.33High4.25Low138.16KlotVolume4.31Open4.31Pre Close59.19MTurnover0.73%Turnover Ratio27.78P/E (Static)1.98BShares5.2352wk High0.83P/B8.00BFloat Cap3.5652wk Low4.74Limit Up1.88BShs Float18.17Historical High3.88Limit Down1.86%Amplitude-1.63Historical Low0.22Dividend TTM4.28Avg Price77.55KlotAsk5.18%Div YieldTTM100Lot Size58.83KlotBid
Huapont Life Sciences News
Huabang Health: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Huabang Health: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Huabang Health: Comparative table of amendments to the company\'s articles of association
Huabang Health: Announcement on the expected launch of forward foreign exchange settlement services and RMB to foreign exchange option combinations in 2025
Huabang Health: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Huabang Health: Board of Directors Rules of Procedure (December 2024)
Huabang Health: Announcement on the non-public issuance of exchangeable corporate bonds
Huabang Health: Announcement on the Wholly-owned Subsidiary Obtaining the “Drug Registration Certificate”
Huabang Health: 2024 Semi-Annual Financial Report
Huabang Health: Half-year summary table of non-operating capital usage and other related capital transactions
Huapont Life Sciences: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Huapont Life Sciences: 2023 Annual General Meeting of Shareholders Legal Opinions
Huapont Life Sciences: Announcement on preparing to accrue asset impairment
Huapont Life Sciences: Announcement on holding an online briefing on the 2023 annual results
Huapont Life Sciences: 2023 Financial Results Report
Huapont Life Sciences: Summary table on the use of non-operating capital and other related capital transactions in 2023
Huapont Life Sciences: Report on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties by the Audit Committee
Huapont Life Sciences: Notice of Annual General Meeting of Shareholders
Huapont Life Sciences: Internal Control Self-Assessment Report
Huabang Health: Notice on Using Temporarily Idle Own Funds for Cash Management
